In AD, it has been proposed that GSK3β could be the link between amyloid peptide and Tau phosphorylation since activation of GSK3β is regulated by signaling pathways targeted by amyloid peptide (Alvarez et al., 1999; Hernández et al., 2010). The gene discussed is GSK3B; the disease is Alzheimer disease.